With a price-to-earnings (or “P/E”) ratio of 15.2x Anhui Anke Biotechnology (Group) Co., Ltd. (SZSE:300009) may be sending bullish signals at the moment, given that almost half of all companies in China have P/E ratios greater than 27x and even P/E’s higher than 51x are not unusual. However, the P/E might be low for a reason and it requires further investigation to determine if it’s justified. With its earnings growth in positive territory compared to the declining earnings of most…
Read More…